Construction and immunogenicity of Salmonella vaccine vector expressing HIV-1 antigen and MCP3

Endang Winiati, P. Coloe, P. Smooker

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


This study aims to determine the efficacy of Salmonella enterica serovar Typhimurium STM-1bearing MCP-3 gene as a delivery vehicle for the HIV gag gene (in particular p24 gene) and HIV env gene. The STM1 delivery HIV-p24 vaccination was carried out in the form of a recombinant or a DNA vaccine whereas only a DNA vaccine was used for HIV env . Naked DNA vaccination was also tested and immune responses were evaluated following immunisation in mouse model. Results: vaccination cellular immune responses induced by recombinant p24 STM1 (STM1/pHly-p24) were greater than those elicited by the p24 DNA vaccine in STM1 (STM1/VR-p24), (but statistically not significant) than those induced by oral vaccination. However, IgA responses induced by oral vaccination with either a recombinant or DNA vaccine of p24 in STM1 are higher than those induced by IP vaccination. In addition, the numbers of cells secreting IL4 are reduced after oral vaccination with STM1/VR-p24/MCP3. However, for the HIV p24 antigen, STM1/MCP3 preferentially induces IFNγ-secreting splenocytes. Conclusions: This result confirms other studies that Salmonella was able to deliver HIV antigens to the immune system and induced specific immune responses to the HIV antigen and for the HIV p24 antigen, STM1/MCP3 induces secretion of IFNγ.

Original languageEnglish
Pages (from-to)403-415
Number of pages13
JournalActa Microbiologica et Immunologica Hungarica
Issue number4
Publication statusPublished - 1 Dec 2009


  • DNA vaccine
  • HIV
  • MCP3
  • Recombinant
  • Salmonella

Fingerprint Dive into the research topics of 'Construction and immunogenicity of Salmonella vaccine vector expressing HIV-1 antigen and MCP3'. Together they form a unique fingerprint.

Cite this